Clinical Trial

A Study of How the Body Absorbs LY3537031

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to find out how much LY3537031 gets into the blood stream and how long it takes the body to get rid of it when it is injected just under the skin in different parts of the body, and when it is injected into a vein, in healthy participants. This study will also look at the safety and tolerability of LY3537031.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-24
notable Primary completion moved earlier: 2026-09 -> 2026-07-17 2026-07-24
minor Completion moved earlier: 2026-09 -> 2026-07-17 2026-07-24
Trial Details
NCT Number NCT07202871
Lead Sponsor Eli Lilly and Company
Conditions Healthy
Enrollment 47 participants
Start Date 2025-11-03
Primary Completion 2026-07-17 (estimated)
Study Completion 2026-07-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-23